- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 8, 2026 | 143.68M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 143.16M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 102.47M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $1.63M |
| Capex restated | Q1 2026 · Mar 31, 2025 | $1.09M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $671K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$13.03M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $37.99M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $39.57M |
| Cash And Equivalents restated | Q1 2026 · Mar 31, 2025 | $42.14M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $54.02M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $64.49M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $102.35M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $118.7M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $61.87M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $63.47M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $79.14M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $82.96M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $76.08M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $89.32M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $133.16M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $147.45M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.21 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.08 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.21 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$11.56M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$21.01M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$11.78M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$21.38M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $6.64M |
| Gross Profit restated | Q1 2026 · Mar 31, 2025 | $7.07M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $14.14M |
| Cost Of Revenue restated | Q1 2026 · Mar 31, 2025 | $13.65M |
| Revenue | Q1 2026 · Mar 31, 2026 | $20.78M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $20.72M |